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In silico study of VP35 inhibitors: from
computational alanine scanning to essential
dynamics†
F. Dapiaggi,a S. Pieraccini*ab and M. Sironi*ab
In recent years the Ebola virus has spread through several countries in Africa, highlighting the need to
develop new treatments for this disease and boosting a new research eﬀort on this subject. The Ebola
virus Viral Protein 35 (VP35) carries out multiple functions necessary for virus replication and infection, in
particular interfering with (IFN)-a/b signaling. Recently, VP35 has been crystallized in complex with small
organic molecules able to inhibit its interaction with viral nucleoproteins, thus reducing Ebola infections
of cultured cells. In this work, starting from these structures, we carry out a computational study aimed
at investigating the energetic and dynamical aspects of the interaction between VP35 and its ligands at
the atomic level. Molecular dynamics simulations, computational alanine scanning, root mean square
fluctuations bootstrap analysis and essential dynamics analysis were performed. Our results expand the
experimental ones obtained in previous works, adding information about the interactions landscape with
the identification of a set of new hot-spots residues exerting a critical function in the protein–ligand
interaction. Moreover we characterized the dynamics of the complexes, showing that the presence of
ligands modifies the overall protein dynamics as well as the behavior of particular protein segments.
Introduction
The Ebola virus (EBOV) and Marburg virus (MARV) are the
causative agents of haemorrhagic fevers with a very high human
fatality rate near 90%.1 Recently EBOV has spread in several
countries in Africa and a few sporadic cases were registered also
in Europe and in the US. The lack of eﬀective therapies or
vaccines, combined with this high mortality rate, makes urgent
the need to develop antiviral drugs against EBOV.
The virulence and high lethality of this virus are due to
diﬀerent factors, in particular to its ability to inhibit both the
innate immune response in the early stages of infection and the
subsequent adaptive specific immune responses of the host
organism.2,3 This is done by diﬀerent strategies, in particular by
the suppression of interferon (IFN)-a/b production and inhibition
of interferon induced antiviral activity.4,5
Ebola’s genome codes for seven proteins. Only one of them,
the viral large (L) RNA-dependent RNA polymerase protein, has
an enzymatic activity, while all the remaining EBOV proteins
exert their function through protein–protein interactions,
among themselves or with human proteins.
In this work we focus our attention on Viral Protein 35 (VP35).
This protein carries out multiple functions, including the inhibition
of RNA-dependent protein kinase (PKR),6,7 suppression of RNA
silencing8 and the inhibition of (IFN)-a/b signaling.9 This makes
VP35 a potential therapeutic target. VP35 consists of a N-terminal
coiled-coil domain, required for its oligomerization, and of a
C-terminal domain, called the interferon inhibitory domain
(IID), required for the interaction with the viral nucleoprotein
(NP) and for interferon inhibition. The high resolution structure
of the C-terminal domain has been recently solved. It is made up
by two diﬀerent subdomains (Fig. 1): a N-terminal a-helical
subdomain and a C-terminal b-sheet subdomain.10,11 In a recent
study Brown et al.10 determined the crystallographic structures
of VP35 in a complex with nine small molecules able to inhibit
the protein–protein interaction between VP35 and NP.
In this work we study at the atomic level the interactions
between these inhibitors and VP35 by performing molecular
dynamics simulations and computational alanine scanning on
these systems, in order to identify the key interactions for the
binding of ligands, thus providing hints for the further optimization
of active molecules targeting VP35. Then, to better characterize
and distinguish the dynamic behavior of the apo-protein from
the ligand–protein complexes we measured residues RMSF
and performed an essential dynamics analysis. We finally
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compared the dynamic behavior of the apo-forms of EBOV and
MARV VP35.
Materials and methods
Molecular dynamics
The ligand–protein complexes and the apo-protein structures of
EBOV and MARV VP35 were obtained from the Protein Data Bank
(PDB codes: 4IBB, 4IBC, 4IBD, 4IBE, 4IBF, 4IBG, 4IBI, 4IBJ, 4IBK,10
3FKE,11 4GH912). Molecular dynamics simulations were performed
with the GROMACS 4.5.313 package using explicit solvent and
periodic boundary conditions. The AMBER99SB-ILDN14 force field
was used for the protein and the Generalized Amber Force Field15
for ligands. Each complex was solvated with TIP3P16 waters and
neutralized with two chloride ions. The LINCS algorithm17 was
employed to constrain all bonds involving hydrogen to their
equilibrium length, allowing a time step of 2 fs. The systems
were submitted to 10000 steps of geometry optimization with
the steepest descent method. Then they were equilibrated for
200 ps in NVT conditions (T = 300 K) and subsequently for 200 ps
in NPT conditions, in order to equilibrate systems density. Then
a 25 ns molecular dynamics was performed for every system in
NPT conditions (1 bar, 300 K). Temperature and pressure were
kept constant to their reference values using the velocity rescale
algorithm18 and the Berendsen barostat respectively.19 A 14 Å
cutoff was applied for non-bonded interactions and the Particles
Mesh Ewald algorithm20 was employed to calculate long range
electrostatic interactions.
Computational alanine scanning
To perform computational alanine scanning, 250 snapshots
were extracted from the last 5 ns of each dynamics (one snap-
shot every 20 ps). Residues at the ligand–protein interface were
selected using Naccess.21 For each residue at the interface all
side chain atoms beyond Cb were removed and the missing
hydrogen was added, obtaining an alanine side chain. DG of
binding was calculated using the MM/PBSA approach.22 In this
protocol it is implicitly assumed that point mutations in the
protein do not significantly affect the conformation of the
mutated protein. The validity of this assumption in computational
alanine scanning has been widely confirmed in literature when it
has been applied both to protein–protein and to protein–small
molecule complexes.23–26 The Poisson–Boltzmann equation was
solved with APBS27 using a relative dielectric constant of 80 for
the region around the protein and of 2 for the protein interior. The
entropic contribution to DG is supposed constant in the mutated
and wild type structure considering their similarity, so it has not
been calculated, as discussed by Kollman et al.28
Bootstrap root mean-square fluctuations (RMSF) analysis
For this analysis we applied the protocol described in the work
by Mitra et al.29 We first determined the number of independent
conformations in our MD trajectories by calculating the autocor-
relation function of Root Mean Square Deviation (RMSD) of the
structures. We found a correlation time of 2.5 ns, corresponding
to 10 independent structures in each of our 25 ns trajectories. In
order to calculate the RMSF we selected 10 random points with
replacement, from every dynamics and repeated it 200 times,
giving us a mean RMSF value and a standard error of the mean
for each residue in the protein. Using these values we applied a
student’s t-test to the data and identified contiguous regions
that showed significant diﬀerences at a significance level of
p o 0.0005.
Essential dynamics
Principal component analysis or essential dynamics30 (ED)
extracts the correlated motions of a protein to understand which
are the most important ones. First of all, the 3N  3N covariance
matrix of positional fluctuations of Ca was calculated:
C = h(x(t)  hxi)(x(t)  hxi)Ti
where x(t) are the atomic coordinates as a function of time and
the brackets denote an ensemble average. Then the covariance
matrix was diagonalized by an orthogonal coordinate transfor-
mation T:
C = TKTT
K is the diagonal matrix containing eigenvalues and every
column of T is an eigenvector of C. Finally the dynamics of
the complexes were projected on the first eigenvectors in
order to analyze the motion. The covariance matrix and its
diagonalization were calculated with the g_covar utility of
GROMACS 4.5.3, the analysis of the eigenvalues and eigen-
vectors with g_anaeig. The visual inspection of the projection
on the first 3 eigenvectors was carried out using the VMD
software.31
Fig. 1 VP35 in complex with one of the ligands (GA017). The a-helical
subdomain (residues from Ala221 to Arg283) is represented in green and
the b-sheet subdomain (residues from Val294 to Ile340) is represented in
blue. The binding mode is the same for all ligands.
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Results and discussion
Computational alanine scanning
A molecular dynamics of 25 ns was performed for the apo-protein
and for every ligand–protein complex. Computational alanine
scanning (CAS) on the residues at the protein–ligand interface
was carried out in the last 5 ns of the molecular dynamics
trajectories, when the system was fully equilibrated in all cases,
as shown by RMSD plots (see Fig. S2–S10, ESI†). In general, once
equilibrium has been reached, trajectories 5 ns long guarantee
enough sampling for an accurate binding free energy calculation
with the MM/PBSA approach and consequently for computational
alanine scanning purposes.32,33 All the complexes exhibit a negative
protein–ligand DG of binding during the simulations (Table S1,
ESI†). The interface is defined as the ensemble of amino acids
whose solvent exposed surface area has a non-zero variation upon
complex formation. Ligand molecules share the same binding site
and 18 residues in total were found to be at the interface for each
molecule. CAS results are summarized in Table 1. Residues whose
mutation led to a variation in ligand binding free energy (DDG)
greater than 2 kcal mol1 are defined hot-spots.
Residue numbering and domain names are taken from
Leung et al.11 In Fig. 1 the two subdomains of VP35 are shown.
The a-helical subdomain consists of residues Ala221–Arg283
and the b-sheet subdomain is formed by residues Val294–
Ile340. The loop Val284–Pro293 connects the two subdomains.
The binding site is the same for all the ligands and it is located
between the a-helical and the b-sheet subdomains.
Six amino acids are found to be hot spots in all the
simulated complexes, namely Lys222, Arg225, Gln244, Lys248,
Lys251 and Ile295 (Fig. 2). Brown et al.10 performed experi-
mental mutation of Lys248 or Ile295 into alanine, showing that
these two residues are of paramount importance for ligands
binding, as their mutation resulted in a near complete loss of
binding aﬃnity for all the tested ligands. Our computational
results mirror the available experimental ones, furthermore
they led to the identification of four new hot-spots residues
exerting a critical function in the protein–ligand interaction. All
the molecules considered in the present study share an almost
equal orientation within the binding pocket, with the common
carboxylic group oriented toward a region of the protein con-
taining a cluster of positive charged residues, such as Lys222,
Lys251, Lys248 and Arg225, which are all hot spots, the most
prominent two being Lys248 and Lys251. Lys251 forms a strong
salt bridge with the carboxylic group of the ligands, which is
observed in all the simulations. The loss of this interaction
upon mutation into alanine explains the high value of DDG of
the residue in all the complexes. In some cases, such as the
GA017, GA246 and VPL29 complexes, the average distance
between the carboxylic carbon and the charged lysine nitrogen
is below 4 Å, the interaction being almost continuously present
during the MD run. In other cases, for example the VPL27
complex, the average distance is around 5 Å, resulting in a lower
DDG. Lys248, although bearing a positive charge, also forms
hydrophobic interactions through its aliphatic chain with the B
and D rings of the ligands (Fig. 3). A coulombic interaction
between opposite charges of Lys248 and the carboxylic group of
the ligands is likely to be also present. Analysing the geometries
Table 1 CAS values for protein–ligand complexes. The hot spots are in bold
Residue number
DDG/kcal mol1
GA017 GA246 VPL27 VPL29 VPL42 VPL48 VPL57 VPL58 VPL60
Lys222 9.80 4.61 4.53 3.35 4.41 5.14 3.39 2.98 3.27
Arg225 9.19 17.28 6.22 4.80 7.47 8.33 5.59 6.27 6.24
Gln241 0.24 1.10 0.65 0.28 0.91 0.72 0.80 0.23 0.26
Gln244 2.75 3.26 4.56 1.96 4.29 2.77 4.54 4.14 4.07
Val245 0.51 0.61 0.77 0.72 0.74 0.65 0.63 0.62 0.69
Cys247 0.21 0.35 0.12 0.32 0.01 0.14 0.21 0.05 0.21
Lys248 9.91 8.73 12.02 14.83 11.16 9.42 14.39 12.63 14.54
Leu249 0.24 0.29 0.60 0.56 0.51 0.67 0.64 0.18 0.62
Lys251 12.96 11.22 8.00 11.14 8.92 10.61 8.43 10.04 10.19
Asp252 1.28 0.85 2.48 4.73 3.51 2.23 5.53 1.97 4.28
Asp289 1.09 1.26 1.05 1.04 1.11 1.05 0.99 1.04 0.98
Val294 0.01 0.03 0.04 0.04 0.03 0.04 0.04 0.06 0.03
Ile295 3.93 5.29 4.78 4.08 4.49 5.24 4.97 4.70 4.76
His296 0.13 0.19 0.18 0.10 0.10 0.04 0.05 0.18 0.16
Ile297 0.23 0.96 0.80 0.78 0.73 1.13 0.87 1.10 0.87
Asp302 0.83 0.97 1.07 0.81 1.03 0.41 1.05 0.93 1.27
Ile303 0.54 0.22 0.06 0.25 0.22 0.29 0.38 0.32 0.15
Phe328 0.38 1.09 0.77 0.83 0.85 1.23 0.67 0.69 0.84
Fig. 2 An overview of the hot-spot residues in the GA017–VP35 complex.
These residues are common to all the complexes studied.
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of the complexes during the simulations and measuring the
average distance between the carboxylic carbon and the charged
lysine nitrogen, it is clear that the contribution of the hydro-
phobic interaction is constant for all the complexes, while the
different values of Lys248 DDG are modulated by electrostatic
interactions during the dynamics. For VPL29 and VPL57, show-
ing the higher DDG value, the mean distance is around 5.5 Å,
instead for VPL48 and GA246 this value is over 7 Å. Lys222 and
Arg225 do not form stable salt bridges during the dynamics, but
they are affected by the proximity of the ligand’s carboxylic
group. Their DDG values are lower than those of the aforemen-
tioned positive charged residues. Ile295 interact with the D and
C aromatic rings of the ligands; these interactions are mainly
hydrophobic. Interestingly, Asp252 exhibit a negative DDG in all
the complexes. This is probably due to its proximity to the
negatively charged carboxylic group of the ligands. Substituting
this residue with an alanine results in the loss of this disadvan-
taged interaction. Asp302 exhibits the same behavior, albeit to a
lower extent (see Table 1).
Root mean-square fluctuations bootstrap analysis
To further characterize the dynamic behavior of EBOV VP35
and how it is aﬀected by ligand binding, Ca root mean-square
fluctuations were calculated for the apo-form and for each
protein–ligand complex. As we can notice in Fig. 4, there are
five protein segments exhibiting a fluctuation larger than
average, corresponding to residues His231–Phe235, Ile246–
Ser253, Ser266–Ser272, Pro293–Ile297 and Phe328–Leu336. Seg-
ments comprising residues His231–Phe235 and Ser266–Ser272
correspond to loop regions connecting a-helices, which have an
intrinsically larger mobility than neighboring residues, so we
focused our analysis on the Ile246–Ser253, Pro293–Ile297 and
Phe328–Leu336 segments (Fig. 5), which all show significant
differences in RMSF between the apo-protein and the com-
plexes, according to student’s t-test. Fig. 4 shows that residues
ranging from Pro293 to Ile297, belonging to the b-sheet sub-
domain, exhibit a higher RMSF value in the apo-form than in
all the complexes. A similar behavior is also evident in residues
ranging from Ile246 to Ser253 belonging to the a-helical sub-
domain. The presence of any ligand reduces the fluctuation of
these two regions which compose the binding site, and they are
thus less flexible upon ligand binding.
Moreover, RMSF exhibits a sharp peak corresponding to the
region between residues Phe328 and Leu336. Here RMSF
reaches values around 0.2 nm for the apo-form and even greater
for the VPL60, VPL57 and VPL58 complexes. These ligands
seem to exalt the flexibility of these residues. Finally, root mean
Fig. 3 The structure of GA017. The pyrrolidinone scaﬀold is common to
all the molecules. Molecular structures of all the simulated ligands can be
found in the ESI† (Fig. S1).
Fig. 4 RMSF bootstrap analysis. Three protein segments have been further analyzed, due to their larger flexibility: Ile246–Ser253, Pro293–Ile297 and
Phe328–Leu336 (see text). A larger version of this figure can be found in the ESI† (Fig. S11).
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square fluctuation analysis was performed on MARV VP35. On the
whole, more flexible loops correspond to those observed in the
EBOV protein (Fig. S12, ESI†), as expected due to the high
homology and great structural similarity between the two proteins.
Essential dynamics
In order to better understand the results arising from RMSF
analysis we performed essential dynamics (ED) calculations on
the apo-protein and on all the simulated complexes. The MD
trajectories were processed by principal components analysis
considering the protein Ca for the construction of the covariance
matrix. For each system, the projection of the trajectory on the
three eigenvectors corresponding to the greater eigenvalues were
visualized. In all the systems the first three eigenvectors repre-
sent at least 30% of the global motion.
The ED analysis of the apo-form of VP35 highlights two
kinds of motions. The projection along the first two eigenvec-
tors describes a closing motion of the b-sheet subdomain on
the a-helical subdomain. In particular loops Pro293–Ile297 and
Phe328–Leu336, both belonging to the b-sheet subdomain,
appear to bend towards the residues Ile246–Ser253 of the
a-helical subdomain (Fig. 6). The projection on the 3rd eigen-
vector shows the motion of the Phe328–Leu336 loop alone.
These results strictly mirror the observations from the RMSF
analysis, where the aforementioned groups exhibited the higher
mobility. For the apo-form the first three eigenvectors describe
more than 50% of the collective motion of the protein.
The presence of some ligands, such as GA017, GA246 and VPL29,
hinders the closing motion observed in the apo-form; the projection
on the first eigenvector of the GA017 complex is the same of the
apo-form, but the amplitude of the motion is smaller. Also in this
case we confirm our previous observation from the RMSF analysis,
as RMSF values for residues Ile246–Ser253 and Pro293–Ile297 of the
complexes were lower than for the apo-protein.
Interestingly, the RMSF analysis suggested that ligands
VPL57, VPL58 and VPL60 could exalt the motion of residues
between Phe328 and Leu336. The projections on the first three
eigenvectors for the VPL60 complex trajectory show an intense
movement of these residues. In this case the characteristic
closing motion observed in the apo-form was not detected,
while it was significantly reduced in VPL57 and VPL58 complexes.
For the VPL60 complex the first three eigenvectors describe about
48% of the global motion. For the VPL57 complex the projections
on the 1st and 2nd eigenvector show a very largemotion of the loop
Phe328–Leu336 (Fig. 7) while the projection on the 3rd eigenvector
describes the closing motion of the b-sheet subdomain towards the
a-helical subdomain.
Fig. 5 Flexible domains of VP35.
Fig. 6 Schematic representation of the projection of the MD simulation
on the 1st eigenvector extracted from the ED of the apo-protein. High-
lighted in orange and green we can see the closing motion of the b-sheet
subdomain towards residues Ile246–Ser253 belonging to the a-helical
subdomain, highlighted in yellow.
Fig. 7 The projection of the MD simulation on the 1st eigenvector of the
VPL57–VP35 complex. Highlighted in green we can see the intense
motion of the Phe328–Leu336 loop. The characterizing closing motion
of the apo-protein is not present in this case.
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Finally, VPL58 has a similar behavior, the projection of the
trajectory on the 1st eigenvector resulting in a large motion of
the Phe328–Leu336 loop and the projections on the 2nd and 3rd
eigenvectors representing the closing motion of the a-helical
subdomain on the b-sheet subdomain. The first three eigenvectors
of both VPL57 and VPL58 describe almost 40% of the collective
motion of the complex.
Interestingly, the crystal structures of the EBOV VP35–RNA
complex suggest that the Phe328–Leu336 loop can be involved
in protein–protein lateral contacts between EBOV VP35 units
during the recognition process of double stranded viral RNA.
These processes have been reported to be critical for the
inhibition of interferon induced antiviral activity and EBOV
virulence,34 thus affecting its dynamics might perturb also this
step of the suppression of host immunity by EBOV. On the
other hand, the Phe328–Leu336 loop seems not to be of crucial
importance for RNA binding in other filoviruses, as discussed
previously.35
Conclusions
In this work we studied EBOV VP35 and its inhibitors from a
computational point of view. We performed MD simulations of
apo-protein and complexes starting from the crystallographic
structures and we performed CAS, obtaining a very good agree-
ment with the structural and biochemical experimental results.
We deepened the study of this systems from the point of view of
the intermolecular interactions, identifying new hot spots in
addition to those experimentally determined. Then we per-
formed the RMSF bootstrap analysis, in order to identify the
most mobile residues and to highlight the diﬀerence between
the apo-protein and the complexes, in particular we identified
three protein segments whose behavior was diﬀerent in the
apo-protein compared to the complexes.
To characterize the RMSF analysis, in order to analyse the
global motion of the systems, we performed ED analysis,
obtaining the collective and most important motion for every
system. We noticed that ligands hinder the typical closing motion
of the b sheet-subdomain towards the a helical-subdomain of the
apo-form. The binding of some ligands, like VPL57 VPL58 and
VPL60, exalt the movement of the loop Phe328–Leu336.
Notes and references
1 H. Feldmann and T. W. Geisbert, Lancet, 2011, 377,
849–862.
2 C. M. Bosio, M. J. Aman, C. Grogan, R. Hogan, G. Ruthel and
D. Negley, et al., J. Infect. Dis., 2003, 188, 1630–1638.
3 M. Bray and T. W. Geisbert, Int. J. Biochem. Cell Biol., 2005,
37, 1560–1566.
4 S. P. Reid, L. W. Leung, A. L. Hartman, O. Martinez, M. L. Shaw
and C. Carbonelle, et al., J. Virol., 2006, 80, 5156–5167.
5 S. P. Reid, C. Valmas, O. Martinez, F. M. Sanchez and
C. F. Basler, J. Virol., 2007, 81, 13469–13477.
6 Z. Feng, M. Cerveny, Z. Yan and B. He, J. Virol., 2007, 81,
182–192.
7 M. Schu¨mann, T. Gantke and E. Mu¨hlberger, J. Virol., 2009,
83, 8993–8997.
8 J. Haasnoot, W. de Vries, E.-J. Geutjes, M. Prins and P. de
Haan, et al., PLoS Pathog., 2007, 3, e86.
9 W. B. Ca´rdenas, Y.-M. Loo, M. Gale Jr., A. L. Hartman,
C. R. Kimberlin, L. Martinez-Sobrido, E. O. Saphire and
C. F. Basler, J. Virol., 2006, 80, 5168–5178.
10 C. S. Brown, et al., J. Mol. Biol., 2014, 426, 2045–2058.
11 D. W. Leung, N. D. Ginder, D. B. Fulton, J. Nix, C. F. Basler,
R. B. Honzatko and G. K. Amarasinghe, Proc. Natl. Acad. Sci.
U. S. A., 2009, 106, 411–416.
12 Bale, et al., PLoS Pathog., 2012, 8, e1002916.
13 B. Hess, C. Kutzner, D. van der Spoel and E. Lindahl,
J. Chem. Theory Comput., 2008, 4, 435–447.
14 K. Lindorﬀ-Larsen, S. Piana, K. Palmo, P. Maragakis,
J. L. Klepeis, R. O. Dror and D. E. Shaw, Proteins, 2010, 78,
1950–1958.
15 J. Wang, R. M. Wolf, J. W. Caldwell, P. A. Kollman and
D. A. Case, J. Comput. Chem., 2004, 25, 1157–1174.
16 W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W. Impey
and M. L. Klein, J. Chem. Phys., 1983, 79, 926–935.
17 B. Hess, H. Bekker, H. J. C. Berendsen and J. G. E. M. Fraaje,
J. Comput. Chem., 1997, 18, 1463–1472.
18 G. Bussi, D. Donadio and M. Parrinello, J. Chem. Phys., 2007,
126, 014101.
19 H. J. C. Berendsen, J. P. M. Postma, W. F. van Gunsteren,
A. DiNola and J. R. Haak, J. Chem. Phys., 1984, 81, 3684–3690.
20 T. Darden, D. York and L. Pedersen, J. Chem. Phys., 1993, 98,
10089–10092.
21 S. Hubbard and J. Thornton, Naccess, The University of
Manchester, UK, 1992–1996.
22 P. A. Kollman, et al., Acc. Chem. Res., 2000, 33, 889–897.
23 S. Huo, I. Massova and P. A. Kollman, J. Comput. Chem.,
2002, 93, 15–27.
24 S. Pieraccini, R. De Gonda and M. Sironi, Chem. Phys. Lett.,
2011, 517, 217–222.
25 S. Huo, et al., J. Comput. Chem., 2002, 23, 15–27.
26 I. S. Moreira, et al., J. Comput. Chem., 2007, 28, 644–654.
27 N. A. Baker, D. Sept, S. Joseph,M. J. Holst and J. A. McCammon,
Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 10037–10041.
28 I. Massova and P. A. Kollman, J. Am. Chem. Soc., 1999, 121,
8133–8143.
29 A. Mitra and D. Sept, Biophys. J., 2008, 95, 3252–3258.
30 A. Amadei, A. B. M. Linssen and H. J. C. Berendsen, Proteins:
Struct., Funct., Genet., 1993, 17, 412–425.
31 W. Humphrey, A. Dalke and K. Schulten, J. Mol. Graphics,
1996, 14, 33–38.
32 T. Huo, J. Wang, Y. Li and W. Wang, J. Chem. Inf. Model.,
2011, 51, 69–82.
33 I. S. Moreira, et al., Theor. Chem. Acc., 2007, 117, 99–113.
34 D. W. Leung, et al., Nat. Struct. Mol. Biol., 2010, 17, 165–172.
35 P. Ramanan, et al., Proc. Natl. Acad. Sci. U. S. A., 2012, 109,
20661–20666.
Paper Molecular BioSystems
Pu
bl
ish
ed
 o
n 
23
 Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ita
 S
tu
di
 d
i M
ila
no
 o
n 
14
/0
9/
20
15
 1
2:
10
:2
5.
 
View Article Online
